A Reuters investigation published in December 2018 found that Johnson & Johnson knew for decades that its baby powder talc sometimes tested positive for asbestos, a known carcinogen, and did not disclose this to regulators or the public. Internal J&J documents dated from the 1970s through the early 2000s showed awareness of asbestos contamination in talc sourced from mines in Vermont and elsewhere. In 2018, a Missouri jury awarded $4.69 billion to 22 women who alleged asbestos-contaminated talc caused their ovarian cancer (Ingham v. Johnson & Johnson). J&J discontinued US and Canadian baby powder sales in 2020 and global sales in 2023. Two attempts to resolve talc liability through bankruptcy of a subsidiary (LTL Management) were rejected by federal courts in 2023.